Clinical Trial Update: Edoxaban for TIA and Acute Minor Stroke [Phase 2, Phase 3]

View source ↗

Summary

This document notes an ongoing phase 2/phase 3 clinical trial evaluating edoxaban for prevention of recurrent ischemic events in patients with transient ischemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Savaysa (edoxaban)

Snippet

Sponsor: Xijing Hospital | Conditions: Ischemia, Stroke | Phase 2, Phase 3 | Status: UNKNOWN